Vaxart managed to create a vaccine that most possibly kills COVID-19 but its side effects are not seen yet as tests are still being conducted in coronavirus infected monkeys. Sintx Technologies is not a biotech firm that deeply focuses on fighting the pandemic but its recent silicon nitride powder could inactivate COVID-19 as the previous tests revealed effectiveness against several single-strand RNA viruses.
If they cooperate to end the serious pandemic that has taken almost half-million lives worldwide a few days could be needed to develop a neutralizing vaccine.
Both (VXRT and SINT) stocks soared significantly due to positive news linked to the COVID-19 vaccine development. The possible collaboration may strengthen their brands and stocks in healthcare industry.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life